Liquid biopsy for disease monitoring after anti-CD19 chimeric antigen receptor T cell in diffuse large B-cell lymphoma.

Clara MaluquerBeatriz BellosilloAlberto MussettiEva Domingo-DomènechRocío ParodyLierni Fernández-IbarrondoRoser VelascoGabriel Moreno-GonzálezGabriela SanzMontserrat CortésAnna Sureda

Published in: EJHaem (2020)

Our case shows how the complementary use of ctDNA and PET-CT scan could be a helpful tool in the clinical management of these patients.

Keyphrases

diffuse large b cell lymphoma
pet ct
end stage renal disease
epstein barr virus
newly diagnosed
chronic kidney disease
computed tomography
prognostic factors
magnetic resonance imaging
ionic liquid
patient reported outcomes
patient reported
circulating tumor cells
circulating tumor